Lanzul

Lansoprazole, the active ingredient in Lanzul, is a proton pump inhibitor presented as an oral tablet for oral use. It reduces gastric acid production and is indicated for conditions such as gastro‑oesophageal reflux disease, peptic ulcer disease, Helicobacter pylori eradication regimens and NSAID‑induced ulcer prophylaxis.

GNH USA supplies Lanzul as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies, transplant centres and oncology centres worldwide, providing reliable sourcing and regulatory support for global healthcare providers through established distribution networks and quality‑assured manufacturing.

Lansoprazole is a proton pump inhibitor used to manage acid‑related gastrointestinal disorders.

Gastro‑oesophageal reflux disease (GERD): reduces reflux symptoms and promotes healing of esophageal erosions. Peptic ulcer disease: facilitates ulcer healing and prevents recurrence. Helicobacter pylori eradication (as part of combination therapy): enhances eradication rates by suppressing acid. NSAID‑induced ulcer prophylaxis: lowers risk of ulcer development in patients on chronic NSAIDs.

Lansoprazole may be associated with adverse reactions, ranging from mild to serious.

Common Side Effects: - Headache - Diarrhea - Abdominal pain - Nausea - Flatulence - Constipation

Serious or Rare Side Effects: - Severe allergic reactions such as anaphylaxis or Stevens‑Johnson syndrome - Clostridioides difficile infection - Hypomagnesemia (low magnesium levels) - Elevated liver enzymes - Acute pancreatitis - Interstitial nephritis

Before starting Lanzul, consider the following precautions.

Assess renal and hepatic function before initiating therapy. Use caution in patients with known hypersensitivity to proton pump inhibitors. Monitor for potential drug interactions, especially with antiplatelet agents. Consider periodic magnesium level checks during long‑term use. Avoid abrupt discontinuation to reduce rebound acid hypersecretion. Store at ambient temperature below 25°C: keep in the original container, protect from moisture and light.

Lansul can interact with several medicines; awareness of major and moderate interactions helps ensure safe use.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet activity. - Atazanavir: decreased absorption leading to loss of antiviral effect. - Methotrexate (high dose): increased toxicity.

Moderate Interactions (Monitor Closely): - Warfarin: possible increase in INR, monitor coagulation. - Digoxin: may raise serum concentrations, monitor levels.